Literature DB >> 23399036

RNA binding by human Norovirus 3C-like proteases inhibits protease activity.

Prasanth Viswanathan1, Jared May, Sunghae Uhm, Changsuek Yon, Brent Korba.   

Abstract

A highly active, fluorescence-based, in vitro assay for human Norovirus protease from genogroup I and II viruses was optimized utilizing as little as 0.25μM enzyme, pH 7.6, and substrate:enzyme of 50-100. Activity in Tris-HCl or sodium phosphate buffers was 2-fold less than HEPES, and 2-fold lower for buffer concentrations over 10mM. Protease activity at pH 7.6 was 73% (GI) or 63% (GII) of activity at the optimal pH 9.0. Sodium inhibited activity 2-3 fold, while potassium, calcium, magnesium, and manganese inhibited 5-10 fold. Differences in efficiency due to pH, buffer, and cations were due to changes in kcat and not Km. Norovirus protease bound short RNAs representing the 3' or 5' ends of the virus, inhibiting protease activity (IC50 3-5μM) in a non-competitive manner. Previous reports indicated participation of the protease in the Norovirus replicase complex. The current studies provide initial support for a defined role for the viral protease in Norovirus replication.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23399036     DOI: 10.1016/j.virol.2013.01.006

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  The p4-p2' amino acids surrounding human norovirus polyprotein cleavage sites define the core sequence regulating self-processing order.

Authors:  Jared May; Prasanth Viswanathan; Kenneth K-S Ng; Alexei Medvedev; Brent Korba
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

2.  Long-Range Communication between Different Functional Sites in the Picornaviral 3C Protein.

Authors:  Yan M Chan; Ibrahim M Moustafa; Jamie J Arnold; Craig E Cameron; David D Boehr
Journal:  Structure       Date:  2016-04-05       Impact factor: 5.006

Review 3.  Treatment of norovirus infections: moving antivirals from the bench to the bedside.

Authors:  Stuart S Kaufman; Kim Y Green; Brent E Korba
Journal:  Antiviral Res       Date:  2014-02-25       Impact factor: 5.970

4.  Presentation overrides specificity: probing the plasticity of alphaviral proteolytic activity through mutational analysis.

Authors:  Valeria Lulla; Liis Karo-Astover; Kai Rausalu; Andres Merits; Aleksei Lulla
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

5.  Selection and Characterization of Rupintrivir-Resistant Norwalk Virus Replicon Cells In Vitro.

Authors:  Mitsutaka Kitano; Myra Hosmillo; Edward Emmott; Jia Lu; Ian Goodfellow
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

6.  The RNA-Binding Site of Poliovirus 3C Protein Doubles as a Phosphoinositide-Binding Domain.

Authors:  Djoshkun Shengjuler; Yan Mei Chan; Simou Sun; Ibrahim M Moustafa; Zhen-Lu Li; David W Gohara; Matthias Buck; Paul S Cremer; David D Boehr; Craig E Cameron
Journal:  Structure       Date:  2017-12-05       Impact factor: 5.006

7.  In crystallo-screening for discovery of human norovirus 3C-like protease inhibitors.

Authors:  Jingxu Guo; Alice Douangamath; Weixiao Song; Alun R Coker; A W Edith Chan; Steve P Wood; Jonathan B Cooper; Efrat Resnick; Nir London; Frank von Delft
Journal:  J Struct Biol X       Date:  2020-07-16

8.  Polyprotein processing and intermolecular interactions within the viral replication complex spatially and temporally control norovirus protease activity.

Authors:  Edward Emmott; Alexis de Rougemont; Myra Hosmillo; Jia Lu; Timothy Fitzmaurice; Jürgen Haas; Ian Goodfellow
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

Review 9.  Norovirus Protease Structure and Antivirals Development.

Authors:  Boyang Zhao; Liya Hu; Yongcheng Song; Ketki Patil; Sasirekha Ramani; Robert L Atmar; Mary K Estes; B V Venkataram Prasad
Journal:  Viruses       Date:  2021-10-14       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.